Zhou Ru, He Pei-Lan, Ren Yong-Xin, Wang Wen-Hai, Zhou Rong-Yao, Wan Hua, Ono Shiro, Fujiwara Hiromi, Zuo Jian-Ping
Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Cancer Sci. 2007 Jun;98(6):882-9. doi: 10.1111/j.1349-7006.2007.00465.x. Epub 2007 Apr 13.
CSA1M tumor-bearing mice exhibited a severe immune dysfunction but the underlying mechanism remained unclear. In this study, we demonstrated that the myeloid suppressor cell (Mac-1(+)Gr-1(+) cells)-(MSC) related T cell immunosuppression in this tumor-bearing model. In mice at the late stage of CSA1M tumor-bearing (Late TB [8-10 weeks after cell inoculation in male BALB/c mice]), the percentages for CD4(+) and CD8(+) T cells decreased but Mac-1(+) cells increased in spleens with severe splenomegaly. There was no deficit for concanavalin A-induced CD4(+) and CD8(+) T cell proliferation, interferon-gamma (IFN-gamma) and interleukin (IL)-4 production, but delayed-type hypersensitivity reaction were attenuated. Analysis of cytokine production in unfractionated spleen cells showed a significant reduction of IFN-gamma and a marked increase of IL-10 and IL-4. In Late-TB mice, splenic MSC number intensively accumulated; the mRNA expressions of the signal transducer and activator of transcription 1, interferon regulatory factor 1 (IRF-1), and inducible nitric-oxide synthase (iNOS) were enhanced in MSC; the nitric oxide production and arginase enzyme activity increased in MSC as well. Furthermore, the concanavalin A-induced T cell proliferation was inhibited in the presence of lipopolysaccharide- or IFN-gamma-activated MSC from Late-TB mice, which could be reversed by the iNOS specific inhibitor L-NMMA. iNOS seemed to be required more than arginase for the suppressive activity of MSC. Taken together, our results suggest that the immune dysfunction in tumor-bearing mice might be causally associated with the accumulation of MSC and its tumor-favoring property.
携带CSA1M肿瘤的小鼠表现出严重的免疫功能障碍,但其潜在机制尚不清楚。在本研究中,我们证明了在该荷瘤模型中髓系抑制细胞(Mac-1(+)Gr-1(+)细胞)相关的T细胞免疫抑制作用。在携带CSA1M肿瘤晚期的小鼠(晚期荷瘤[雄性BALB/c小鼠细胞接种后8 - 10周])中,脾脏中CD4(+)和CD8(+) T细胞百分比下降,但Mac-1(+)细胞增加,伴有严重脾肿大。伴刀豆球蛋白A诱导的CD4(+)和CD8(+) T细胞增殖、干扰素-γ(IFN-γ)和白细胞介素(IL)-4产生没有缺陷,但迟发型超敏反应减弱。对未分离的脾细胞中细胞因子产生的分析显示IFN-γ显著减少,IL-10和IL-4显著增加。在晚期荷瘤小鼠中,脾脏髓系抑制细胞数量大量积累;髓系抑制细胞中转录信号转导子和激活子1、干扰素调节因子1(IRF-1)以及诱导型一氧化氮合酶(iNOS)的mRNA表达增强;髓系抑制细胞中一氧化氮产生和精氨酸酶活性也增加。此外,在存在来自晚期荷瘤小鼠的脂多糖或IFN-γ激活的髓系抑制细胞的情况下,伴刀豆球蛋白A诱导的T细胞增殖受到抑制,这可被iNOS特异性抑制剂L-NMMA逆转。对于髓系抑制细胞的抑制活性,iNOS似乎比精氨酸酶更重要。综上所述,我们的结果表明荷瘤小鼠的免疫功能障碍可能与髓系抑制细胞的积累及其促肿瘤特性有因果关系。